1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Transfusion management in the era of magrolimab (Hu5F9-G4), an anti-CD47 monoclonal antibody therapy
- Contribution to journal › Scientific review
- 2019
-
Mark
Follicular Lymphoma : Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs
- Contribution to journal › Article
- 2016
-
Mark
Drug utilization research in the area of cancer drugs
(2016) p.315-327
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
Adaptive mitochondrial reprogramming and resistance to PI3K therapy
- Contribution to journal › Article
-
Mark
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling
- Contribution to journal › Article
- 2014
-
Mark
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer
- Contribution to journal › Article
- 2013
-
Mark
Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors
- Contribution to journal › Article
- 2012
-
Mark
Oleic acid is a key cytotoxic component of HAMLET-like complexes
- Contribution to journal › Article
-
Mark
Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K
- Contribution to journal › Article
- 2011
-
Mark
A novel method for preparation of HAMLET-like protein complexes
- Contribution to journal › Article
